Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Faraday Discussions|January 25, 2008
MicroParticle photophysics illuminates viral bio-sensingS Arnold, R Ramjit, D Keng, et al.
The Journal of Biological Chemistry|December 25, 1989
Characterization and platelet inhibitory activity of bitistatin, a potent arginine-glycine-aspartic acid-containing peptide from the venom of the viper Bitis arietansR J Shebuski, D R Ramjit, G H Bencen, et al.
Thrombosis and Haemostasis|December 28, 1990
Prevention of canine coronary artery thrombosis with echistatin, a potent inhibitor of platelet aggregation from the venom of the viper, Echis carinatusR J Shebuski, D R Ramjit, G R Sitko, et al.
Circulation|February 1, 1992
Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosisG R Sitko, D R Ramjit, I I Stabilito, et al.
Thrombosis and Haemostasis|March 1, 1995
Vampire bat salivary plasminogen activator evokes minimal bleeding relative to tissue-type plasminogen activator as assessed by a rabbit cuticle bleeding time modelM J Mellott, D R Ramjit, I I Stabilito, et al.
Circulation|July 1, 1991
Effective thrombolysis without marked plasminemia after bolus intravenous administration of vampire bat salivary plasminogen activator in rabbitsS J Gardell, D R Ramjit, I I Stabilito, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1993
Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosisD R Ramjit, J J Lynch, G R Sitko, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1995
Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383J J Lynch, J J Cook, G R Sitko, et al.
Elife|July 25, 2024
Hippo pathway-mediated YAP1/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiationYifan Wu, Kunhua Qin, Yi Xu, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217J J Cook, M A Holahan, E A Lyle, et al.
Pageof 1